Hycanthone methanesulfonate (HCT) was shown to induce "forward" and "reverse" mutations in Salmonella typhimurium and Escherichia coli. Mutational effects of HCT on S. typhimurium TA1532 were concentration and time dependent. A comparison of mutagenic potency for TA1532 was made between HCT and the frame-shift mutagens quinacrine and ICR-191. An investigation of structure-activity relationships revealed the substituent in the 4-position of ring A to be critical for mutagenicity. Activity was found when this group was a hydroxymethyl (i.e., HCT) or an aldehyde (Win 25,315), but the analogues having a carboxyl group (Win 25,850) Hycanthone (HCT) (1-diethylaminoethylamino-4-hydroxymethyl-thiaxanthone; Etrenol) is a clinically effective chemotherapeutic agent that has been widely used since 1969 for the treatment of schistosomiasis, especially in severe, acute Schistosoma mansoni infections where it can be a life-saving drug (5, 12, 13, 15, 20) . HCT is known to interact with deoxyribonucleic acid (DNA) in vitro, apparently by intercalation (11, 19) . It produces a variety of genetic effects in microbial and cell culture systems, including mutagenicity for Salmonella and bacteriophage T4 (8, 9), mutagenicity for mouse lymphoma cells (6), and cell transformation in rat embryo cell cultures infected with Rauscher leukemia virus (10). Furthermore, it has been slAown that HCT induces P22 prophage in Salmonella typhimurium (16 General growth conditions. Exponentially multiplying cultures were prepared in the mineral salts medium of Vogel and Bonner (18) with 0.5% glucose. This was supplemented with L(+)-histidine hydrochloride (100 ug/ml) alone or in combination with d-biotin (1.4 ug/ml) for the histidine auxotrophs and the histidine-biotin-uvrB mutants, respectively. Flasks (500-ml Erlenmeyer) containing 100 ml of mineral salts basal medium plus 0.005% glucose were inoculated and incubated for 16 h at 37 C in a shaking water bath (200 rpm; Metabolyte shaker, New Brunswick Scientific Co., New Brunswick, N.J.), after which the glucose concentration was increased to 0.5% and incubation was continued until growth was exponential.
Hycanthone methanesulfonate (HCT) was shown to induce "forward" and "reverse" mutations in Salmonella typhimurium and Escherichia coli. Mutational effects of HCT on S. typhimurium TA1532 were concentration and time dependent. A comparison of mutagenic potency for TA1532 was made between HCT and the frame-shift mutagens quinacrine and ICR-191. An investigation of structure-activity relationships revealed the substituent in the 4-position of ring A to be critical for mutagenicity. Activity was found when this group was a hydroxymethyl (i.e., HCT) or an aldehyde (Win 25,315), but the analogues having a carboxyl group (Win 25,850) or methyl group (lucanthone) in this position were inactive. Removal of a single ethyl group from the side chain did not affect mutagenic activity inasmuch as the potency of desethyl HCT (Win 27,262) equaled that of HCT on a molar basis. A marginal activity was found with a sample of HCT sulfokide (win 27,366), but this sample was found to contain traces of HCT. The HCT analogue with a terminal N-oxide in the side chain (Win 29,329) was inactive at the concentration tested.
Hycanthone (HCT) (1-diethylaminoethylamino-4-hydroxymethyl-thiaxanthone; Etrenol) is a clinically effective chemotherapeutic agent that has been widely used since 1969 for the treatment of schistosomiasis, especially in severe, acute Schistosoma mansoni infections where it can be a life-saving drug (5, 12, 13, 15, 20) . HCT is known to interact with deoxyribonucleic acid (DNA) in vitro, apparently by intercalation (11, 19) . It produces a variety of genetic effects in microbial and cell culture systems, including mutagenicity for Salmonella and bacteriophage T4 (8, 9) , mutagenicity for mouse lymphoma cells (6) , and cell transformation in rat embryo cell cultures infected with Rauscher leukemia virus (10) . Furthermore, it has been slAown that HCT induces P22 prophage in Salmonella typhimurium (16) . We now present additional information concerning HCT and related compounds as bacterial mutagens.
MATERIALS AND METHODS
Bacterial cultures. A series of histidine-less auxotrophs of S. typhimurium, with (TA1530, TA1531, TA1532, TA1534) or without (hisG46, hisC207, hisC3076, hisD3052) and additional deletion in the DNA excision repair (uvrB) and biotin loci, and previously shown to be suitable for mutagenicity testing, was kindly supplied by Bruce N. Ames General growth conditions. Exponentially multiplying cultures were prepared in the mineral salts medium of Vogel and Bonner (18) with 0.5% glucose. This was supplemented with L(+)-histidine hydrochloride (100 ug/ml) alone or in combination with d-biotin (1.4 ug/ml) for the histidine auxotrophs and the histidine-biotin-uvrB mutants, respectively. Flasks (500-ml Erlenmeyer) containing 100 ml of mineral salts basal medium plus 0.005% glucose were inoculated and incubated for 16 h at 37 C in a shaking water bath (200 rpm; Metabolyte shaker, New Brunswick Scientific Co., New Brunswick, N.J.), after which the glucose concentration was increased to 0.5% and incubation was continued until growth was exponential.
Qualitative mutagenicity screening test. The qualitative spot-plate agar diffusion procedure of Ames (2) was used for preliminary testing of chemical mutagens.
Quantitative measurement of reversion to histidine independence in TA1532. Mutagens were added to exponentially multiplying cultures of TA1532 (approximately 3 x 106 colony-forming units/ml), and at intervals 6-ml samples were removed aseptically, membrane filtered (Millipore Corp., 0.45 um), and washed with 3 volumes and resuspended in 2 volumes of sterile basal medium without glucose, histidine, or biotin. Viability of the resuspended cells was determined by plating in quadruplicate suitable dilutions in tryptone glucose extract agar (Difco). Histidineindependent mutants ("revertants") were detected by spreading 0.1-ml portions of suitable dilutions of resuspended cells on plates of mineral salts-glucose medium with biotin (1.4 Mg/ml) but without histidine. To aid mutant colony detection, triphenyltetrazolium chloride (50 ug/ml) was included in the plating agar. 
RESULTS
Screening tests for mutagenicity of HCT and related compounds. In our hands, the rapid qualitative spot-test procedure gave results consistent with those of Ames (2) and of Hartman et al. (9) . Alkylating agents were detected by the pair G46 and TA1530, and frame-shift mutagens were detected by some or all of the remaining pairs ( Table 1) . As previously reported by Hartman et al. (8, 9) , HCT (but not LCT) caused frame-shift mutations in the DNA excision repair-defective strains TA1532 and TA1534. Little or no effect of HCT was seen with the corresponding strains possessing normal excision repair capacity (i.e., C3076 and D3052). It was noted further that a number of other DNA-binding agents, including chloroquine, quinine sulfate, and ethidium bromide, did not show mutagenic activity in this system. Next, this procedure was used to examine structure-activity relationships in a series of compounds related to HCT. The substituent in the 4-position of ring A was important for conferring mutagenic properties ( Q^uantitative determination of mutagenic potency of HCT. A method for specifying the potency of mutagens then was sought by using TA1532, which had shown a response to HCT and to both of the reference frame-shift mutagens, ICR-191 and quinacrine. Exponentially growing cultures of TA1532 in mineral saltsglucose medium were exposed to HCT for 60 min, membrane filtered to remove excess drug, and examined for viability and histidineindependent back mutants. Detailed results of one such test are presented in Table 3 . Treatment with approximately 1.1 x 10-i M HCT (50 jg/ml) decreased viability by some 90% and increased the mutant frequency among the survivors 360-fold over that of the untreated control. Extensive killing was not required for the mutagenic effect, because a substantial increase (19-fold) in mutant frequency occurred with the 25 gg/ml treatment, which did not completely halt growth of the culture.
The above procedure was used to compare the effect of concentration of several compounds on mutant frequency (Fig. 1) . It was found that, on a molar basis, HCT and desethyl HCT were of equal potency. Because the curves for ICR-191 and quinacrine have different slopes from the curve for HCT, relative mutagenic potency of the three compounds depends on the concentration used. If one arbitrarily selects the concentration needed to increase mutant frequency 20-fold, then HCT (6 x 10-' M) is approximately two times less active than quinacrine (3 x 10-' M) and about 47 times less effective than ICR-191 (1.3 x 10-6 M). On the other hand, at low concentrations (< 2 x 10-' M), HCT was slightly more mutagenic than quinacrine.
Influence of duration of exposure on mutagenic action of desethyl HCT. The 60-min incubation period used in the previous tests was chosen arbitrarily, and it was found that prolonging the treatment time with either HCT or desethyl HCT produced greater numbers of mutants. Results of a representative experiment using desethyl HCT (20 ,g/ml or 6 x 10-5 M) are shown in Fig. 2 . Growth of the treated culture continued during the first 30 min of exposure and then ceased, and after 90 min of incubation the viable count began to fall. Mutant frequency had increased by approximately 6.5-fold at 30 min and continued to increase more slowly for the next 60 min. Beyond 90 min, and paralleling the onset of the bactericidal effect, mutant frequency of the treated culture increased markedly. After 180 min of exposure, mutant frequency reached 86 times that of the control culture (which contained Me2SO at a concentration equal to that in the treated culture). Similar results were found with HCT. An increased mutagenic effect of HCT with time also was evident in the data of Hartman et al.
(8).
Antibacterial potency of HCT and other mutagens for DNA excision repair-competent and -defective strains. Hartman et al. might be more susceptible to the growth-inhibitory effects of HCT. The wild-type LT-2 and the histidine auxotroph hisC3076 showed no difference in the MIC value for HCT (both 250 ,ug/ml), but TA1532 (i.e., hisC3076 with additional deletion through uvrB and bio) was five times more sensitive (Table 4) . A similar fivefold difference in sensitivity was observed with quinacrine and acriflavin. With mitomycin C the difference in sensitivity was about 50-fold.
Induction -of forward mutations of azetidine resistance in S. typhimurium LT-2. It was considered essential to demonstrate that the mutagenic activity of HCT was not limited simply to reversion to prototrophy in the two histidine auxotrophs TA1532 and TA1534, both of which originally had been derived by using a frame-shift mutagen. For this purpose we adopted a suggestion of Ames (2) that the forward mutation to resistance to L-azetidine-2-carboxylic acid was a suitable general test for mutagenicity. Treatment of exponentially growing cultures of the wild-type strain LT-2 with several known mutagens resulted in appropriate increases in the numbers of organisms able to form colonies on azetidine-containing agar (Table 5) . HCT treatment produced significant mutagenic effects at concentrations exceeding 100 ,ug/ml (2.2 x 10-4 M) but gave only marginal responses at lower concentrations. A 16-fold increase in mutant frequency over that of the untreated control was obtained with 3.5 x 10-4 M HCT (160 ig/ml). This apparently lower mutagenic potency of HCT for LT-2 compared with TA1532 is consistent with the differences in growth-inhibitory properties of HCT noted in Table 4 .
Forward mutation to valine resistance in nongrowing cell suspensions of E. coli ATCC 12435. A further test of the ability of HCT to induce forward mutations was made by using a method described by Adelberg et al. (1) . This involved determination of the increase in the number of organisms resistant to L-valine during exposure of a nongrowing cell suspension of E. coli ATCC 12435 to the mutagens. Mutagenic action of the alkylating agent, N-methyl-N-nitro-N-nitrosoguanidine, was readily demonstrable, whereas the frame-shift mutagens, ICR-191 and quinacrine, were ineffective at the levels tested (Table 6 ). This lack of activity was not due simply to nonspecific resistance, because both agents were inhibitory to growth at these concentrations (for both quinacrine and ICR-191, the MIC value was 25 sg/ml). Several unsuccessful attempts were made to obtain (8, 9) , leave no doubt that HCT acts as a mutagen for bacteria. We now can rule out arguments that the action of HCT might be limited to reversion to prototrophy in the specific mutants used by Hartman, or that the effect might be an artifact due to HCT resistance of histidine-independent revertants.
That HCT functions as a mutagen is perhaps not unexpected in view of its ability to bind to DNA in vitro (11, 19) . It is clear, however, that intercalation or other DNA-binding properties in themselves are insufficient to confer mutagenic capacity. A number of known DNA-binding agents, including chloroquine, ethidium bromide, and LCT, failed to show mutagenicity in the Salmonella test system. As pointed out by Hartman et al. (8) , the lack of activity by LCT cannot be ascribed simply to a failure to penetrate into the cell, because its antibacterial potency is the same or greater than that of HCT. In fact, a rather specific molecular structure is needed for detectable mutagenic properties by HCT and its congeners. Of the compounds tested, only the desethyl HCT retained full activity. Other alterations greatly reduced or abolished mutagenicity. Because of the thinlayer chromatography results, it is possible to argue that the slight effect seen with the aldehyde and the marginal activity of the sulfoxide actually resulted from trace contamination with HCT. It is equally possible that these compounds are truly weakly active and that the multiple spots observed on thin-layer chromatograms were due to some sort of complex formation or salts effects. It is known that HCT preparations contain a small amount (< 1%) of a simple complex of two molecules of HCT (E. W. Dennis, personal communication).
It is interesting that a mutagenic effect of HCT should be observed with nongrowing cells of E. coli. Frame-shift mutagens are considered to have a preferential action on the replicating chromosome (14) . This suggests that HCT might conceivably act some way in addition to simple intercalation, and Hartman et al. (8) have postulated that a metabolite with alkylating properties might be formed. Possibly the restrictions on molecular structure that we observed could be related to the capability of producing such an activated form. In the case of the E. coli experiments, it is possible also that HCT simply was bound to the nongrowing cells and exerted the mutational effect only later, when the cells began to divide on the plating medium. If so, this would imply a stronger binding than occurs with quinacrine and ICR-191, which failed to produce an effect under the same conditions.
Clearly the DNA excision repair system potentiates both the bactericidal and mutagenic effects of HCT. Hartman et al. (8) found a substantially greater mutagenic effect by HCT in the DNA repair-defective (uvrB) strains. We also observed increased sensitivity to the antibacterial action of HCT in these strains. This enhancement of potency in excision repairdefective strains might argue for some sort of damage to the chromosome during HCT treatment. Because similar increases in sensitivity were observed with quinacrine and acriflavin, any such postulated effect does not appear to be unique to HCT. With mitomycin C, which cross-links double-stranded DNA (17) , this effect was one order of magnitude greater than with HCT.
With respect to mutagenicity detection systems, it is useful to have the greater sensitivity provided by DNA repair-defective strains. On the other hand, it would seem that the wildtype would yield the more realistic appraisal of mutagenic potency in practice, since most bacteria may be expected to possess repair systems. HCT can exert mutagenic effects whether or not the DNA excision repair system is present, as shown by mutation of the wild-type strain LT-2. With either allele, HCT appears to be a less potent mutagen than quinacrine or Actually, the interest in mutagenic properties of HCT arises not so much from intrinsic significance of its effects on bacteria as from extrapolations that have been made from bacteria to humans (9) . The crux of all such considerations is, of course, the predictive value of the bacterial tests, which is not at all clear. Ames et al. (3, 4) have made a rather good case for the proposition that many (although perhaps not all) proven chemical carcinogens act as bacterial mutagens. At present, however, we are not persuaded of the validity of the converse of the proposition, namely, that all bacterial mutagens will act as carcinogens. Indeed, if one were to accept that line of reasoning, quinacrine would appear to be the better candidate for consideration because it seems to be more potent as a bacterial mutagen 
